DealsMidEuropa buys majority stake in Famar from ECM, Metric CapitalFamar is a pharmaceutical CDMO.ByIrien Joseph22 July 2024•2 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsEuropeUKWestern EuropeHealthcare